Male Contraception Study

WHRU - Male Contraception Study

In this study, we are using Nestorone® to see if it will block the production of male hormones needed to make sperm. Nestorone® is a hormone that has been used in research studies to suppress ovulation in females. Nestorone® gel is an experimental drug which has not been approved by the United States Food and Drug Administration (FDA). An additional part of this study is to see how much Nestorone® and testosterone is transferred from the skin of the male subject to the female subject after he applies the combined study gel to his skin as well as how well this medication works

You may be eligible if you:

Men

  • You are between the ages of 18 and 50
  • In good general health
  • In a stable, mutually monogamous relationship with a woman for at least one year

Women

  • You are between the ages of 18 and 34
  • You have regular menstrual cycles every 21-35 days
  • You are in good general health
  • You are currently using contraception to prevent pregnancy but are willing to use only the study gel as your main form of contraception once you enter into the Efficacy Phase

Compensation

Men may be compensated up to $1,900 depending on the number of study visits you complete. Women may be compensated up to $700 depending on the number of study visits you complete.

Whom do I contact for additional information?

To find out more information and to learn if you are qualified to participate, please call the Women's Health Research Unit confidential recruitment line at 503-494-3666 or email us at whru@ohsu.edu.